1. |
Kakunaga S, Ikeda W, Itoh S, et al. Nectin-like molecule-1/TSLL1/SynCAM3: a neural tissue-specific immunoglobulin-like cell-cell adhesion molecule localizing at non-junctional contact sites of presynaptic nerve terminals, axons and glia cell processes. J Cell Sci 2005; 118:1267-77.
|
2. |
Zhou Y, Du G, Hu X, et al. Nectin-like molecule 1 is a protein 4.1N associated protein and recruits protein 4.1N from cytoplasm to the plasma membrane. Biochim Biophys Acta 2005; 1669:142-54.
|
3. |
Dong X, Xu F, Gong Y, et al. Crystal structure of the V domain of human Nectin-like molecule-1/Syncam3/Tsll1/ Igsf4b, a neural tissue-specific immunoglobulin-like cell- cell adhesion molecule. J Biol Chem 2006; 281:10610-7.
|
4. |
Ogita H, Takai Y. Nectins and nectin-like molecules: roles in cell adhesion, polarization, movement, and proliferation. IUBMB Life 2006; 58:334-43.
|
5. |
Fukuhara H, Kuramochi M, Nobukuni T, et al. Isolation of the TSLL1 and TSLL2 genes, members of the tumor suppressor TSLC1 gene family encoding transmembrane proteins. Oncogene 2001; 20:5401-7.
|
6. |
Gao J, Chen T, Liu J, et al. Loss of NECL1, a novel tumor suppressor, can be restored in glioma by HDAC inhibitor-Trichostatin A through Sp1 binding site. Glia 2009; 57:989-99.
|
7. |
Gao J, Chen T, Yin B, et al. Effect of NECL1 on the proliferation of T98G glioma cell line. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2008; 30:280-3.
|
8. |
Yin B, Chen T, Gao J, et al. Neural adhesion molecule NECL1 inhibits migration, invasion, and potentially induces differentiation of glioma cell. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2009; 31:669-73.
|
9. |
Prince CW, Oosawa T, Butler WT, et al. Isolation, characterization, and biosynthesis of a phosphorylated glycoprotein from rat bone. J Biol Chem 1987; 262:2900-7.
|
10 |
Wai PY, Kuo PC. Osteopontin: regulation in tumor metastasis. Cancer Metastasis Rev 2008; 27:103-18.
|
11 |
Shevde LA, Das S, Clark DW, et al. Osteopontin: an effector and an effect of tumor metastasis. Curr Mol Med 2010; 10:71-81.
|
12 |
Jan HJ, Lee CC, Shih YL, et al. Osteopontin regulates human glioma cell invasiveness and tumor growth in mice. Neuro Oncol 2010; 12:58-70.
|
13 |
Agarwal D, Chen T, Irby R, et al. Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling. J Natl Cancer Inst 2002; 94:513-21.
|
14 |
Wang D, Yamamoto S, Hijiya N, et al. Transcriptional regulation of the human osteopontin promoter: functional analysis and DNA-protein interactions. Oncogene 2000; 19:5801-9.
|
15 |
Lamour V, Le Mercier M, Lefranc F, et al. Selective osteopontin knockdown exerts anti-tumoral activity in a human glioblastoma model. Int J Cancer 2010; 126:1797- 805.
|